Ban Pharmaceuticals from advertising on TV

[DRSE (eagans)]

Also, consider the following.

Repurposed drugs should never be over-riden by emergency use for new patents

Emergency use legislation should never be used to over ride repurposed drugs with censoring and propaganda in order to promote patents and new drugs or vaccines. This is harmful to the public. If this means there needs to be legislation to permit both that may be the compromise. But never again should we see the censoring and propaganda attack on Doctors and Scientists who discovered successful use of repurposed drugs or vitamins could be used instead of a new genetic therapy or vaccine or med…

and

Stop people like Fauci - Steps to Pharm Reform -STOP PHARM FROM GREED

Repeal the 1980 Bayh-Dole Act Repeal the 1986 National Childhood Vaccine Injury Act Repeal the 2004 Project Bioshield Act Repeal the 2005 PREP Act Outlaw Direct-to-Consumer Pharmaceutical Advertising Encode Medical Freedom into Federal Law This article explains in detail why: https://brownstone.org/articles/six-simple-steps-to-pharma-reform/ " By allowing the NIH authority to assign publicly funded intellectual property rights and statutory power to protect exclusive use of them, the Bayh-Do…

and

Repurposed drugs should never be over-riden by emergency use for new patents

Emergency use legislation should never be used to over ride repurposed drugs with censoring and propaganda in order to promote patents and new drugs or vaccines. This is harmful to the public. If this means there needs to be legislation to permit both that may be the compromise. But never again should we see the censoring and propaganda attack on Doctors and Scientists who discovered successful use of repurposed drugs or vitamins could be used instead of a new genetic therapy or vaccine or med…

and

OrphanDrug Act (ODA) - 2 million dollars per year for one patient

Orphan Act was passed for good intentions. Pharm has abused those good intentions. It was passed to encourage pharmaceutical manufacturers to develop treatments for rare diseases affecting fewer than 200,000 individuals in the United States. Pharm is given taxpayer money to research and develop drugs in this category, provided tax breaks and given extended ownership of the drug or patent blocking other companies from producing it or a cheaper generic version. These drugs even though they ser…